Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer

Cisplatin-based chemotherapy has been associated with durable disease control in a small subset of patients with metastatic urothelial cancer. However, the mechanistic basis for this phenomenon has remained elusive. Antitumor immunity may underlie these exceptional responders. In a phase II trial ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Anker, Jonathan, Pal, Sumanta K, Kim-Schulze, Seunghee, Wang, Huan, Halperin, Rebecca, Uzilov, Andrew, Imai, Naoko, Eikawa, Shingo, Saito, Takuro, Sebra, Robert, Hahn, Noah M, Patel, Manishkumar, Qi, Jingjing, Xie, Hui, Bhardwaj, Nina, Gnjatic, Sacha, Galsky, Matthew D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445357/
https://www.ncbi.nlm.nih.gov/pubmed/37607770
http://dx.doi.org/10.1136/jitc-2023-007613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445357/
https://www.ncbi.nlm.nih.gov/pubmed/37607770
http://dx.doi.org/10.1136/jitc-2023-007613

Ejemplares similares